MF Researcher Database

Researcher Database

Advance

Iyoda Masayuki

■FacultyMicrobiology and Immunology
■PositionProfessor
Last Updated :2025/04/01

Researcher

基本情報

Profile and Settings

  • 氏名

    Iyoda Masayuki

Affiliation

  • Microbiology and Immunology, Professor

Location

  • Hatanodai Campus

Degree

  • Doctor of Medical Science, Showa University, Mar. 2005

Achievements

Published Papers

  • Group2 innate lymphoid cells ameliorate renal fibrosis and dysfunction associated with adenine-induced CKD., Nagashima Ryuichi;Ishikawa Hiroki;Kuno Yoshihiro;Kohda Chikara;Eshima Koji;Iyoda Masayuki, Cellular immunology, 401-402, May 2024, Peer-reviewed
  • In vitro investigation of the effects of Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 exopolysaccharides on tight junction damage caused by influenza virus infection., Ishikawa Hiroki;Kuno Yoshihiro;Yokoo Takehiro;Nagashima Ryuichi;Takaki Takashi;Sasaki Hiraku;Kohda Chikara;Iyoda Masayuki, Letters in applied microbiology, 77(4), 2024, Peer-reviewed
  • Effects of NKT Cells on Metabolic Disorders Caused by High-Fat Diet Using CD1d-Knockout Mice, Hiroki Ishikawa, Ryuichi Nagashima, Yoshihiro Kuno, Hiraku Sasaki, Chikara Kohda, Masayuki Iyoda, Diabetes, Metabolic Syndrome and Obesity, 19(16):2855 - 2864, Sep. 2023, Peer-reviewed, DOI:10.2147/DMSO.S428190
  • Effects of NKT Cells on Metabolic Disorders Caused by High-Fat Diet Using CD1d-Knockout Mice, Hiroki Ishikawa, Ryuichi Nagashima, Yoshihiro Kuno, Hiraku Sasaki, Chikara Kohda, Masayuki Iyoda, Diabetes, Metabolic Syndrome and Obesity, 19(16):2855 - 2864, Sep. 2023, Peer-reviewed, DOI:10.2147/DMSO.S428190
  • Exopolysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 prevent influenza virus infection and attenuate secondary bacterial infection risk., Ishikawa H, Kuno Y, Kohda C, Sasaki H, Nagashima R, Iyoda M., Lett Appl Microbiol., 74(5):632 - 639, May 2022, Peer-reviewed, DOI:10.1111/lam.13649
  • 腎炎・ネフローゼ症候群の基礎と臨床, 伊與田　雅之, 昭和学士会雑誌, 81(6):515 - 519, Mar. 2022, Peer-reviewed
  • A case of acute poststreptococcal glomerulonephritis complicated by interstitial nephritis related to streptococcal pyrogenic exotoxin B., KANAZAWA Nobuhiro;IYODA Masayuki;HAYASHI Junichi;HONDA Kazuho;ODA Takashi;HONDA Hirokazu, Pathol Int, 72(3):200 - 206, Mar. 2022, Peer-reviewed, DOI:10.1111/pin.13203
  • The Roles of Kidney-Resident ILC2 in Renal Inflammation and Fibrosis., NAGASHIMA Ryuichi;IYODA Masayuki, Front Immunol, 12:688647, Jul. 2021, Peer-reviewed
  • Crescentic IgA nephropathy after administration of human monoclonal interleukin-12/23p40 antibody in a patient with Crohn's disease: a case report., KANAZAWA Nobuhiro;WADA Yukihiro;AKIYAMA Minako;SHIKIDA Yasuto;SUGIYAMA Motonori;ABE Maki;IYODA Masayuki;HONDA Kazuho;SHIBATA Takanori, CEN Case Rep, 9(3):204 - 209, Aug. 2020, Peer-reviewed
  • Oral administration of trehangelin-A alleviates metabolic disorders caused by a high-fat diet through improvement of lipid metabolism and restored beneficial microbiota., ISHIKAWA Hiroki;INO Satoshi;NAKASHIMA T;MATSUO H;TAKAHASHI Y;KOHDA Chikara;ŌMURA S;IYODA Masayuki;TANAKA Kazuo, Obes Res Clin Pract, 14(4):360 - 367, Jul. 2020, Peer-reviewed
  • Therapeutic Potential of Thrombomodulin in Renal Fibrosis of Nephrotoxic Serum Nephritis in Wistar-Kyoto Rats., KANAZAWA Nobuhiro;IYODA Masayuki;TACHIBANA Shohei;MATSUMOTO Kei;WADA Yukihiro;SUZUKI Taihei;ISERI Ken;SHIBATA Takanori, Kidney Blood Press Res, 45(3):391 - 406, May 2020, Peer-reviewed
  • A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schönlein purpura nephritis and IgA nephropathy., SUGIYAMA Motonori;WADA Yukihiro;KANAZAWA Nobuhiro;TACHIBANA Shohei;SUZUKI Taihei;MATSUMOTO Kei;IYODA Masayuki;HONDA Hirokazu;SHIBATA Takanori, PloS One, 15(4):e0232194, Apr. 2020, Peer-reviewed
  • Membranous nephropathy caused by rheumatoid arthritis., IIDA Ayana;WADA Yukihiro;HAYASHI Junichi;TACHIBANA Shohei;INABA Taro;IYODA Masayuki;HONDA Kazuho;SHIBATA Takanori, CEN Case Rep, 8(4):233 - 238, Nov. 2019, Peer-reviewed
  • Serum uromodulin is associated with the severity of clinicopathological findings in ANCA-associated glomerulonephritis., TACHIBANA Shohei;IYODA Masayuki;SUZUKI Taihei;KANAZAWA Nobuhiro;ISERI Ken;WADA Yukihiro;MATSUMOTO Kei;SHIBATA Takanori, PloS One, 14(11):e0224690, Nov. 2019, Peer-reviewed
  • Elimination of intravenous alendronate by hemodialysis: A kinetic study., ISERI Ken;WATANABE Makoto;LEE Xiao-Pen;YAMADA Miho;RYU Kakei;IYODA Masayuki;UCHIDA Naoki;SATO Keizo;SHIBATA Takanori, Hemodial Int, 23(4):466 - 471, Oct. 2019, Peer-reviewed
  • Effects of Denosumab and Alendronate on Bone Health and Vascular Function in Hemodialysis Patients: A Randomized, Controlled Trial., ISERI Ken;WATANABE Makoto;YOSHIKAWA H;MITSUI H;ENDO T;YAMAMOTO Y;IYODA Masayuki;RYU Kakei;INABA Taro;SHIBATA Takanori, J Bone Miner Res, 34(6):1014 - 1024, Jun. 2019, Peer-reviewed
  • 胆嚢仮性動脈瘤破裂による胆道出血を呈した維持血液透析患者の1例, 松本　啓;金澤　伸洋;鈴木　泰平;森川　友喜;稲葉　大朗;伊與田　雅之;山宮　知;坂木　理;吉田　仁;柴田　孝則, 日本透析医学会雑誌, 52(3):185 - 190, Mar. 2019, Peer-reviewed
  • Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy., WADA Yukihiro;MATSUMOTO Kei;SUZUKI Taihei;SAITO Tomohiro;KANAZAWA Nobuhiro;TACHIBANA Shohei;ISERI Ken;SUGIYAMA Motonori;IYODA Masayuki;SHIBATA Takanori, PloS One, 13(11):e0206865, Nov. 2018, Peer-reviewed
  • Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar-Kyoto rats through anti-inflammatory effects., TACHIBANA Shohei;IYODA Masayuki;MATSUMOTO Kei;WADA Yukihiro;SUZUKI Taihei;ISERI Ken;KANAZAWA Nobuhiro;SHIBATA Takanori, Nephrol Dial Transplant, :e, Jul. 2018, Peer-reviewed
  • ステロイド抵抗性の抗アクアポリン4抗体陽性視神経炎に対し二重膜濾過血漿交換療法が奏功した1例, 福田　桂;伊與田　雅之;齋藤　友広;荒井　典子;和田　幸寛;鈴木　幸恵;木崎　順一郎;恩田　秀寿;高橋　春男;柴田　孝則, 日本透析医学会雑誌, 51(6):379 - 385, Jun. 2018, Peer-reviewed
  • Erlotinib attenuates the progression of chronic kidney disease in rats with remnant kidney., YAMAMOTO Yasutaka;IYODA Masayuki;TACHIBANA Shohei;MATSUMOTO Kei;WADA Yukihiro;SUZUKI Taihei;ISERI Ken;Saito Tomohiro;FUKUDA-HIHARA Kei;SHIBATA Takanori, Nephrol Dial Transplant, 33(4):598 - 606, Apr. 2018, Peer-reviewed
  • The effects of denosumab and alendronate on glucocorticoid-induced osteoporosis in patients with glomerular disease: A randomized, controlled trial., ISERI Ken;IYODA Masayuki;WATANABE Makoto;MATSUMOTO Kei;SANADA Daisuke;INOUE Takashi;TACHIBANA Shohei;SHIBATA Takanori, PloS One, 13(3):e0193846, Mar. 2018, Peer-reviewed
  • Rituximab for the treatment of type B insulin resistance syndrome: a case report and review of the literature., ISERI Ken;IYODA Masayuki;SHIKIDA Yasuto;INOKUCHI Takako;MORIKAWA Tomoko;HARA Noriko;HIRANO Tsutomu;SHIBATA Takanori, Diabet Med, 34(12):1788 - 1791, Dec. 2017, Peer-reviewed
  • ウロモジュリンの腎疾患への関与と新規治療薬としての可能性, 伊與田　雅之;橘　翔平;鈴木　泰平;柴田　孝則, 細胞, 49(10):515 - 519, Sep. 2017
  • ウロモジュリンの腎疾患への関与と新規治療薬としての可能性, 伊與田　雅之;橘　翔平;鈴木　泰平;柴田　孝則, BIO Clinica, 32(5):512 - 517, May 2017
  • A Novel Mutation in a Japanese Family with X-linked Alport Syndrome, ABE Yoshifusa;IYODA Masayuki;NOZU Kandai;HIBINO Satoshi;HIHARA Kei;YAMAGUCHI Yutaka;YAMAMURA Tomohiko;MINAMIKAWA Shogo;IIJIMA Kazumoto;SHIBATA Takanori;ITABASHI Kazuo, Intern Med, 55(19):2843 - 2847, Oct. 2016, Peer-reviewed
  • Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats., ISERI Ken;IYODA Masayuki;OHTAKI Hirokazu;MATSUMOTO Kei;WADA Yukihiro;SUZUKI Taihei;YAMAMOTO Yasutaka;SAITO Tomohiro;HIHARA Kei;TACHIBANA Shohei;HONDA Kazuho;SHIBATA Takanori, Am J Physiol Renal Physiol, 310(11):F1182 - F1191, Jun. 2016, Peer-reviewed
  • Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy, FUKUDA Kei;IYODA Masayuki;TACHIBANA Shohei;ISERI Ken;SAITO Tomohiro;YAMAMOTO Yasutaka;SUZUKI Taihei;WADA Yukihiro;MATSUMOTO Kei;SHIBATA Takanori, PloS One, 11(6):e0158154, Jun. 2016, Peer-reviewed
  • Streptococcal Infection-related Nephritis (SIRN) Manifesting Membranoproliferative Glomerulonephritis Type I., ISERI Ken;IYODA Masayuki;YAMAMOTO Yasutaka;KOBAYASHI Naoto;ODA Takashi;YAMAGUCHI Yutaka;SHIBATA Takanori, Intern Med, 55(6):647 - 650, May 2016, Peer-reviewed
  • Combination Therapy of Denosumab and Calcitriol for a Renal Transplant Recipient with Severe Bone Loss due to Therapy-Resistant Hyperparathyroidism., WADA Yukihiro;IYODA Masayuki;ISERI Ken;ARAI-NUNOTA Noriko;Saito Tomohiro;HAMADA Toma;TACHIBANA Shohei;IKEDA Misa;SHIBATA Takanori, Tohoku J Exp Med, 238(3):205 - 212, Mar. 2016, Peer-reviewed
  • Light-Chain Deposition Disease Successfully Treated with Bortezomib in an Elderly Patient: A Case Report and Review of the Literature., WADA Yukihiro;IYODA Masayuki;Saito Tomohiro;ARAI-NUNOTA Noriko;ISERI Ken;TOMITA Eiko;IKEDA Misa;YAMAGUCHI Yutaka;SHIBATA Takanori, Intern Med, 54(22):2893 - 2898, Nov. 2015, Peer-reviewed
  • 薬剤性急性腎障害, 伊與田　雅之;日原　桂;井芹　健;柴田　孝則, 昭和学士会雑誌, 75(4):421 - 425, Aug. 2015, Peer-reviewed
  • A case of sporadic medullary cystic kidney disease type 1 (MCKD1) with kidney enlargement complicated by IgA nephropathy., SUZUKI Taihei;IYODA Masayuki;YAMAGUCHI Yutaka;SHIBATA Takanori, Pathol Int, 65(7):379 - 382, Jul. 2015, Peer-reviewed
  • Epidermal growth factor receptor inhibition with erlotinib partially prevents cisplatin-induced nephrotoxicity in rats., WADA Yukihiro;IYODA Masayuki;MATSUMOTO Kei;SHINDO Yuki;KUNO Yoshihiro;YAMAMOTO Yasutaka;SUZUKI Taihei;SAITO Tomohiro;ISERI Ken;SHIBATA Takanori, PloS One, 9(11):e111728, Nov. 2014, Peer-reviewed
  • 【腎臓にとって脂質とは何なのだろう】糖尿病性腎症と脂質代謝, 伊與田　雅之;日原　桂;井芹　健;柴田　孝則, 腎と透析, 77(3):337 - 341, Sep. 2014
  • 【ネフローゼ症候群:病因・病態と治療に関する最新の知見】 ネフローゼ症候群と治療　エビデンスと使い方　シクロスポリン, 伊與田　雅之;鈴木　泰平;柴田　孝則, 腎と透析, 76(6):837 - 840, Jun. 2014
  • Therapeutic effects of human mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis., SUZUKI Taihei;IYODA Masayuki;SHIBATA Takanori;OHTAKI Hirokazu;MATSUMOTO Kei;KAWAGUCHI Mio;SHIODA Seiji;AKIZAWA Tadao, PloS One, 8(6):e67475, Jun. 2013, Peer-reviewed
  • 腎疾患に対する薬剤の使用方法　腎静脈・深部静脈血栓症, 伊與田　雅之;鈴木　泰平;秋澤　忠男, 腎と透析, 74(増刊):268 - 270, Apr. 2013
  • Membranous nephropathy that first presented in pregnancy., AOSHIMA Yumie;IYODA Masayuki;NAKAZAWA Ai;YAMAGUCHI Yutaka;KUROKI Aki;SHIBATA Takanori;AKIZAWA Tadao, Intern Med, 52(17):1949 - 1952, Mar. 2013, Peer-reviewed
  • Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis., IYODA Masayuki;SHIBATA Takanori;WADA Yukihiro;KUNO Yoshihiro;SHINDO Yuki;MATSUMOTO Kei;AKIZAWA Tadao, Nephrol Dial Transplant, 28(3):576 - 584, Mar. 2013, Peer-reviewed
  • Basic nephrology　分子生物学 選択的チロシンキナーゼ阻害薬の腎炎・腎不全進行抑制薬としての可能性, 伊與田　雅之;柴田　孝則;秋澤　忠男, Annual Review腎臓, 2013:88 - 94, Jan. 2013
  • IL-17A stimulates granulocyte colony-stimulating factor production via ERK1/2 but not p38 or JNK in human renal proximal tubular epithelial cells., HIRAI Yuki;IYODA Masayuki;SHIBATA Takanori;KUNO Yoshihiro;KAWAGUCHI Mio;HIZAWA Nobuyuki;MATSUMOTO Kei;WADA Yukihiro;KOKUBU Fumio;AKIZAWA Tadao, Am J Physiol Renal Physiol, 302(2):F244 - F250, Jan. 2012, Peer-reviewed
  • 腎間質線維化のメカニズム, 伊與田　雅之;和田　幸寛;秋澤　忠男, BIO Clinica, 26(12):1085 - 1089, Nov. 2011
  • Nilotinib attenuates renal injury and prolongs survival in chronic kidney disease., IYODA Masayuki;SHIBATA Takanori;HIRAI Yuki;KUNO Yoshihiro;AKIZAWA Tadao, J Am Soc Nephrol, 22(8):1486 - 1496, Aug. 2011, Peer-reviewed
  • Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats., KUNO Yoshihiro;IYODA Masayuki;SHIBATA Takanori;HIRAI Yuki;AKIZAWA Tadao, Br J Pharmacol, 162(6):1389 - 1400, Mar. 2011, Peer-reviewed
  • A case of tuberculous peritonitis in a hemodialysis patient with high serum soluble interleukin-2 receptor and CA-125 levels., KUNO Yoshihiro;IYODA Masayuki;AOSHIMA Yumie;HOSAKA Nozomu;SANADA Daisuke;HIRAI Yuki;SHIBATA Takanori;AKIZAWA Tadao, Intern Med, 49(16):1783 - 1786, Aug. 2010, Peer-reviewed

Presentations

  • Effects of exopolysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 on tight junction disruption caused by influenza virus infection, Hiroki Ishikawa, Ryuichi Nagashima, Yoshihiro Kuno, Takashi Takaki, Chikara Kohda, Hiraku Sasaki, Masayuki Iyoda, The 70th Annual Meeting of the Japanese Society for Virology, 27 Sep. 2023, 仙台
  • Effects of estrogen and progesterone on the reactivation of latent cytomegalovirus, 幸田力、石川裕樹、久野芳裕、長島隆一、伊與田 雅之, 第70回日本ウイルス学会学術集会, 26 Sep. 2023
  • Characterization of Rodentibacter sp. that is closely related to Rodentibacter haemolyticus, 佐々木 啓，上芝 秀博，柳澤 直子，石川 裕樹，伊與田 雅之，池 郁 生, The 96th Annual Meeting of Japanese Society for Bacteriology, 17 Mar. 2023, 姫路
  • 自己抗体から紐解く疾患の病理病態　膜性腎症の発症メカニズム　原因抗原と免疫複合体沈着機序に対する理解の変遷, 本田 一穂;康 徳東;伊與田 雅之, 第112回日本病理学会総会, Mar. 2023
  • Exopolysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 inhibit influenza virus infection and attenuate risk of secondary bacterial infection, 石川裕樹、久野芳裕、幸田力、佐々木啓、長島隆一、狩野宏、石井祥子、伊與田雅之, The 69th Annual Meeting of the Japanese Society for Virology, 13 Nov. 2022, 長崎
  • 2型自然リンパ球(ILC2)は腎間質線維化を軽減する, 長島 隆一;石川 裕樹;久野 芳裕;幸田 力;伊與田 雅之, 第65回日本腎臓学会学術総会, 10 Jun. 2022
  • NKT cells contribute to murine norovirus clearance by inducing the virus-specific secretory IgA in intestine, 石川　裕樹;佐々木　啓;幸田　力;久野　芳裕;長島　隆一;田中　和生;伊與田　雅之, 第68回日本ウイルス学会学術集会, 16 Nov. 2021, 神戸・オンライン
  • 腎間質線維化における2型自然リンパ球（ILC2）の役割, 長島　隆一;石川　裕樹;久野　芳裕;幸田　力;伊與田　雅之, 第20回 氷川フォーラム, 13 Nov. 2021, Web開催
  • 腎間質線維化における2型自然リンパ球（ILC2）の役割, 長島　隆一;石川　裕樹;久野　芳裕;幸田　力;伊與田　雅之, 第20回 氷川フォーラム, 13 Nov. 2021, Web開催
  • T cell mediated rejection in a kidney transplant recipient after administration of anti-tuberculous drugs, 金澤　伸洋;伊與田　雅之;吉武　理;本田　一穂;本田　浩一, 第50回日本腎臓学会東部学術大会, 26 Sep. 2020, LIVE配信
  • A case of post-streptococcal acute glomerulonephritis complicated by interstitial nephritis, 金澤　伸洋;伊與田　雅之;福田　桂;林　純一;本田　一穂;本田　浩一, 第50回日本腎臓学会東部学術大会, 26 Sep. 2020, LIVE配信
  • ウステキヌマブ投与後に半月体形成性IgA腎症を呈したクローン病の一例, 金澤　伸洋;和田　幸寛;式田　康人;杉山　元紀;伊與田　雅之;本田　一穂;柴田　孝則, 第49回日本腎臓学会東部学術大会, 05 Oct. 2019, 東京
  • 抗IL-34抗体によるマウスCisplatin腎症進展抑制効果, 和田　幸寛;松本　啓;金澤　伸洋;橘　翔平;鈴木　泰平;伊與田　雅之;柴田　孝則, 第62回日本腎臓学会学術総会, 23 Jun. 2019, 名古屋
  • ANCA関連血管炎における血清・尿中ウロモジュリンの臨床的意義, 橘　翔平;伊與田　雅之;金澤　伸洋;井芹　健;鈴木　泰平;和田　幸寛;松本　啓;柴田　孝則, 第62回日本腎臓学会学術総会, 23 Jun. 2019, 名古屋
  • 遺伝子組み換えトロンボモジュリンのラット抗GBM抗体腎炎における腎不全進行抑制効果と機序の検討, 金澤　伸洋;伊與田　雅之;松本　啓;和田　幸寛;鈴木　泰平;井芹　健;橘　翔平;柴田　孝則, 第62回日本腎臓学会学術総会, 21 Jun. 2019, 名古屋
  • 紫斑病性腎炎とIgA腎症の異同についての検討, 杉山　元紀;和田　幸寛;金澤　伸洋;鈴木　泰平;松本　啓;伊與田　雅之;柴田　孝則, 第62回日本腎臓学会学術総会, 21 Jun. 2019, 名古屋
  • The therapeutic potential of thrombomodulin in renal fibrosis of nephrotoxic serum nephritis in WKY rats, KANAZAWA Nobuhiro;IYODA Masayuki;MATSUMOTO Kei;WADA Yukihiro;鈴木　泰平;ISERI Ken;TACHIBANA Shohei;SHIBATA Takanori, 56th ERA-EDTA Congress, 14 Jun. 2019, Budapest
  • A case of fibrillarry glomerulonephritis associated with fibrinogen., KANAZAWA Nobuhiro;KANG Dedong;IYODA Masayuki;SANADA Daisuke;SAITO Tomohiro;SUGIYAMA Motonori;TAKAKI Takashi;HONDA Kazuho;SHIBATA Takanori, 第7回日本・中国腎生検病臨カンファレンス, 13 Jan. 2019, 越谷
  • 腎線維化におけるEpithelial mesenchymal transition (EMT)と matrix metalloproteinase 14 (MMP14) の関連の検討, 松本　啓;和田　幸寛;橘　翔平;金澤　伸洋;井芹　健;鈴木　泰平;伊與田　雅之;柴田　孝則, 第22回腎間質障害研究会, 08 Sep. 2018, 東京
  • 腎線維化におけるEpithelial mesenchymal transition(EMT)とmatrix metalloproteinase 14(MMP14)の関連の検討, 松本　啓;和田　幸寛;橘　翔平;金澤　伸洋;福田　桂;井芹　健;齋藤　友広;鈴木　泰平;伊與田　雅之;柴田　孝則, 第61回日本腎臓学会学術総会, 09 Jun. 2018, 新潟
  • 糸球体腎炎患者におけるステロイド性骨粗鬆症に対するデノスマブとアレンドロネートの治療効果の比較検討, 井芹　健;伊與田　雅之;渡辺　誠;松本　啓;和田　幸寛;眞田　大介;井上　隆;橘　翔平;柴田　孝則, 第61回日本腎臓学会学術総会, 08 Jun. 2018, 新潟
  • ネフローゼ症候群を呈したIgA腎症の臨床的検討と腎予後, 齋藤　友広;和田　幸寛;伊與田　雅之;安田　隆;安田　宜成;川村　哲也;丸山　彰一;鈴木　祐介;成田　一衛;柴田　孝則, 第61回日本腎臓学会学術総会, 08 Jun. 2018, 新潟
  • 気腫性腎盂腎炎による敗血症にエンドトキシン吸着療法(PMX-DHP)、持続的血液濾過透析(CHDF)を行った一例, 松本　啓;森川　友喜;金澤　伸洋;橘　翔平;眞田　大介;伊與田　雅之;柴田　孝則, 第47回日本腎臓学会東部学術大会, 29 Oct. 2017, 横浜
  • Monoclonal IgA-λ型によるIgA血管炎の一例, 高橋　剛;保坂　望;本田　浩一;福田　桂;丸田　雄一;伊與田　雅之;九島　巳樹;本田　一穂;柴田　孝則, 第47回日本腎臓学会東部学術大会, 28 Oct. 2017, 横浜
  • 慢性リンパ性白血病(CLL)との関連性が考えられた巣状分節性糸球体硬化症(FSGS)の一例, 金澤　伸洋;伊與田　雅之;稲葉　大朗;式田　康人;眞田　大介;本田　一穂;山口　裕;柴田　孝則, 第47回日本腎臓学会東部学術大会, 28 Oct. 2017, 横浜
  • 慢性リンパ性白血病との関連性が考えられた巣状分節性糸球体硬化症の1例, 金澤　伸洋;伊與田　雅之;稲葉　大朗;式田　康人;眞田　大介;本田　一穂;山口　裕;柴田　孝則, 第634回日本内科学会関東地方会, 09 Jul. 2017, 東京
  • 慢性リンパ性白血病との関連性が考えられた巣状分節性糸球体硬化症の1例, 金澤　伸洋;伊與田　雅之;稲葉　大朗;式田　康人;眞田　大介;本田　一穂;山口　裕;柴田　孝則, 第18回東京腎炎・ネフローゼ研究会, 24 Jun. 2017, 東京
  • 維持血液透析患者に発症した化膿性胸鎖関節炎の一例, 松本　啓;山本　康隆;橘　翔平;日原　桂;森川　友喜;眞田　大介;伊與田　雅之;柴田　孝則, 第62回日本透析医学会学術集会・総会, 16 Jun. 2017, 横浜
  • 胆道出血を合併した維持血液透析患者の一例, 金澤　伸洋;松本　啓;鈴木　泰平;角藤　哲;山宮　知;伊與田　雅之;吉田　仁;柴田　孝則, 第62回日本透析医学会学術集会・総会, 16 Jun. 2017, 横浜
  • 培養近位尿細管上皮細胞におけるウロモジュリンの抗炎症効果, 橘　翔平;伊與田　雅之;福田　桂;井芹　健;鈴木　泰平;山本　康隆;齋藤　友広;和田　幸寛;松本　啓;柴田　孝則, 第60回日本腎臓学会学術総会, 27 May 2017, 仙台
  • 膜性増殖性糸球体腎炎III型を呈したIgG3-λ型proliferative glomerulonephritis with monoclonal IgG deposits(PGNMID)の一例, 森川　友喜;伊與田　雅之;式田　康人;山本　康隆;井芹　健;猪口　貴子;稲葉　大朗;本田　一穂;山口　裕;柴田　孝則, 第46回日本腎臓学会東部学術大会, 07 Oct. 2016, 東京
  • ウロモジュリンのラット抗GBM抗体腎炎抑制効果とそのメカニズムの検討, 鈴木　泰平;伊與田　雅之;橘　翔平;日原　桂;井芹　健;山本　康隆;齋藤　友広;和田　幸寛;柴田　孝則, 第59回日本腎臓学会学術総会, 17 Jun. 2016, 横浜
  • 劇症型抗リン脂質抗体症候群(CAPS)が疑われ血漿交換(PE)を含む集学的治療を行った一例, 林　純一;松本　啓;眞田　大介;橘　翔平;日原　桂;森川　友喜;辻田　裕昭;伊與田　雅之;小林　洋一;柴田　孝則, 第61回日本透析医学会学術集会・総会, 12 Jun. 2016, 大阪
  • 心肺蘇生後に発症した両側腎皮質壊死にて透析導入となった一例, 森川　友喜;伊與田　雅之;式田　康人;井芹　健;猪口　貴子;柴田　孝則, 第61回日本透析医学会学術集会・総会, 11 Jun. 2016, 大坂
  • MPO-ANCA関連腎炎再燃における退院時MPO-ANCA陰性化の臨床的意義(第2報), 齋藤　友広;伊與田　雅之;和田　幸寛;渡辺　誠;鈴木　泰平;井芹　健;山本　康隆;日原　桂;松本　啓;柴田　孝則, 第58回日本腎臓学会学術総会, 06 Jun. 2015, 名古屋
  • ラット抗GBM抗体腎炎におけるウロモジュリンの予防および治療効果の検討, 鈴木　泰平;伊與田　雅之;日原　桂;井芹　健;山本　康隆;齋藤　友広;久野　芳裕;和田　幸寛;松本　啓;柴田　孝則, 第58回日本腎臓学会学術総会, 05 Jun. 2015, 名古屋
  • Bortezomib・Dexamethasone(BD)療法が奏功したLight-chain deposition disease(LCDD)の一例, 齋藤　友広;和田　幸寛;伊與田　雅之;荒井　典子;井芹　健;齋藤　文護;中牧　剛;山口　裕;柴田　孝則, 第44回日本腎臓学会東部学術大会, 25 Oct. 2014, 東京
  • 単クローン性IgAの沈着を伴う半月体形成性糸球体腎炎の一例, 眞田　大介;伊與田　雅之;井芹　健;池田　美紗;冨田　瑛子;齋藤　友広;本田　浩一;山口　裕;柴田　孝則, 第44回日本腎臓学会東部学術大会, 25 Oct. 2014, 東京
  • 上皮成長因子受容体阻害薬エルロチニブのラットシスプラチン腎症抑制効果, 和田　幸寛;伊與田　雅之;松本　啓;新藤　優紀;久野　芳裕;鈴木　泰平;山本　康隆;井芹　健;齋藤　友広;柴田　孝則, 第57回日本腎臓学会学術総会, 06 Jul. 2014, 横浜
  • 感染性心内膜炎に細菌性髄膜炎を合併し重篤な経過を辿った、血液透析患者の一剖検例, 齋藤　友広;伊與田　雅之;池田　美紗;小林　直人;柴田　孝則, 第59回日本透析医学会学術集会・総会, 14 Jun. 2014, 神戸
  • 遺伝子組み換え型ヒトトロンボモジュリンのラット抗GBM抗体腎炎進行抑制効果, 松本　啓;伊與田　雅之;柴田　孝則;和田　幸寛;新藤　優紀;久野　芳裕;秋澤　忠男, 第55回日本腎臓学会学術総会, 01 Jun. 2012, 横浜
  • Recombinant human soluble thrombomodulin attenuates anti-glomerular basement membrane glomerulonephritis in Wistar-Kyoto rats., MATSUMOTO Kei;IYODA Masayuki;SHIBATA Takanori;WADA Yukihiro;HIRAI Yuki;KUNO Yoshihiro;AKIZAWA Tadao, 49th Congress of European Renal Association-European Dialysis Transplant Association, 24 May 2012, Paris
  • Therapeutic effects of mesenchymal stem cells in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis, MATSUMOTO Kei;IYODA Masayuki;SHIBATA Takanori;HIRAI Yuki;KUNO Yoshihiro;AIZAWA Tadao, Kidney Week 2011:American Society of Nephrology, 10 Nov. 2011, Philadelphia

Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.